Sequential proteolysis of the amyloid precursor protein (APP) and amyloid-β peptide (Aβ) release 34
The Amyloid Precursor Protein (APP) has been extensively studied as the precursor of the amyloid-58 β peptide (Aβ), the major component of the senile plaques which are a typical hallmark of 59
Alzheimer's disease (AD). Still, the physiological functions of APP per se have been largely 60 overlooked and remain a matter of controversy. Understanding the physiological function of APP 61 and how its deregulation would contribute to AD pathogenesis is thus of prime interest. 62 APP is a type 1 transmembrane protein that belongs to the APP-like protein family (APLP1 and  63 APLP2, referred to as APLPs), which are present in most of the species, excepted in yeast, 64
prokaryotes and plants. The APLP family has been generated by several duplications and 65 contraction events during evolution. The specific physiological role and/or redundant functions 66 assigned to each member are yet not clearly defined (for a review see Shariati and De Strooper, 67 2013) . APP-/-mice show a subtle phenotype, with reduced body and brain weight, reduced 68 locomotor activity, gliosis, mild axonal growth/white matter defects and altered long-term 69 potentiation responses (Guo et al., 2012; Muller et al., 2012; Muller and Zheng, 2012) . In this broad 70 (and complex) picture, growing evidence indicate that APP controls neuronal proliferation, 71
differentiation (Freude et al., 2011; Hu et al., 2013) and migration during embryogenesis (Young-72 Pearse et al., 2007) . APP contributes to the establishment of a functional neuronal network by 73 promoting neurite outgrowth (Hoe et al., 2009b) . Additionally, APP was reported to control 74 synaptic formation and activity (Priller et al., 2006; Santos et al., 2009; Lee et al., 2010; Pierrot et 75 al., 2013; Klevanski et al., 2015; Zou et al., 2016) in the central nervous system (CNS) and at the 76 neuromuscular junction (Stanga et al., 2016) . APP directly modulates the excitatory 77 neurotransmission by interacting with AMPA (Lee et al., 2010) or NMDA (Cousins et al., 2009; 78 Hoe et al., 2009a) receptors. APP was also described to play an important role in GABAergic 79 inhibitory neurotransmission. APP deficiency reduces paired pulse depression (PPD) in mice 80 (Seabrook et al., 1999) and affects GABA receptors expressions (Fitzjohn et al., 2000; Chen et al., 81 2017) , while APP overexpression induces hyperexcitability due to GABAergic neurotransmission 82 failure (Born et al., 2014) . Recently, APP was associated with the GABA excitatory/inhibitory shift 83 occurring in embryonic neurons (Doshina et al., 2017 ). APP appears therefore to have a direct role 84 in the fine-tuning of excitatory and inhibitory neurotransmission, a process that seems to be also 85 critical in AD pathogenesis. 86
Tuning inhibitory/excitatory neurotransmission is very important for neuronal plasticity and 87 memory formation. This is regulated by a specific subset of genes induced by neuronal activity, 88
belonging to the Immediate Early Genes (IEGs) family, which control the mechanisms that 89
"reshape" synaptic inputs on neurons (West and Greenberg, 2011) . IEGs expression is instrumental 90
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Sigma-Aldrich (St Louis, MO, USA). Proteins were quantified with BCA Protein Assay kit 134 (Thermo Fisher Scientific, Waltham, MA) . NuPAGE® reagents were from Invitrogen (Carlsbad, 135 CA). PVDF and nitrocellulose membranes were from Merck Millipore (Billerica, MA,) or 136
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Primary neurons culture and treatments 162
Primary cultures of cortical neurons were prepared from E18 mouse embryos as previously 163
described (Pierrot et al., 2013) . Briefly, cortices were dissected and dissociated in HBSS without 164 calcium and magnesium and the mixture was centrifuged on Fetal Bovine Serum (FBS) for 10 min 165 at 1000xg to pellet cells. Cells were plated at 200.000 cells/cm² in culture dishes pre-treated with 166 10 µg/ml of poly-L-lysine in phosphate buffered saline (PBS) and cultured for 3 to 14 days in vitro 167
in Neurobasal® medium enriched with 2% v/v B-27® supplement medium and 1mM L-glutamine 168 at 37°C, 5% CO2 and humidified atmosphere. Half of the medium was renewed every 2-3 days. 169
After 6 days (DIV6), neurons were treated for 16h with 1µM of N-[N-(3,5-Difluorophenacetyl)-L-170 alanyl]-S-phenylglycine t-butyl ester (DAPT), a γ-secretase inhibitor (Dovey et al., 2001) or with 171 20 nM of soluble APP alpha in Neurobasal® Medium 172
Primary astrocytes culture and treatments 173
Cortices from rat pups were collected at postnatal day 2 and mechanically dissociated. Astrocytes 174
were isolated using a 30% Percoll gradient and seeded into gelatin-coated tissue culture flasks. 175
Cells were left to proliferate for 14 days at 37°C -5% CO2 in DMEM-glutaMAX medium 176
supplemented with 10% FBS, 50 mg/ml penicillin-streptomycin and 50 mg/ml fungizone. Medium 177 was renewed after 7 days, cells were passaged after 14 days and further cultured in DMEM-178 glutaMAX with 10% FBS. Two days later, FBS was reduced to 3% and medium was supplemented 179
with the growth factor cocktail G5. All experiments were conducted 7 days later (DIV7). 180
Npas4 induction analysis 181
For Npas4 induction analysis, neurons and astrocytes at DIV7 were depolarized with 50mM 182 potassium chloride. Cell lysates were analyzed by Western blotting with the anti-Npas4 antibody. 183 as described below. 184 199 Relative quantification was calculated by the 2 ΔΔCT method, and results were normalized first to 200
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Gapdh expression and then normalized (percentage or fold) to the control condition. Primers used 201 are depicted in Table 1 in Supplementary material. 202
Western blotting 203
Cells were solubilized and sonicated in lysis buffer (20% Glycerol, 4% SDS, 125 mM Tris-HCl 204 pH 6.8) containing a cocktail of proteases and phosphatases inhibitors. Mice were euthanized 205 (Ketamine/Xylazine injection) and brains were dissected after perfusion with ice cold sterile PBS. 206
Cortices and hippocampi were isolated and quickly frozen in liquid nitrogen until use. Tissues were 207 crushed using mortar pestle method. For brain protein extraction, samples were homogenized in 208
RIPA buffer (1% (w/v) NP40, 0.5% (w/v) deoxycholic acid, 0.1% (w/v) SDS, 150 mM NaCl, 1 209 mM EDTA, 50 mM Tris, pH 7.4) containing proteases and phosphatases inhibitors cocktail (Roche, 210
Basel, Switzerland). The samples were clarified by centrifugation at 20,000 x g. Protein 211
concentrations were determined with a BCA kit. Samples were prepared with NuPAGE LDS 212 sample buffer (4x) and 50 mM DTT and then heated for 10 min at 70°C. 10 to 40 µg of proteins or 213 22 µl of culture medium were loaded per well for migration followed by transfer onto PVDF or 214 nitrocellulose membranes. For APP C-terminal fragments blotting, proteins were transferred on 215 nitrocellulose (0.1 µm). Membranes were blocked in nonfat dry milk (5% in PBS, 0,1% Tween-216 20) and immunoblotted with anti-APP NT (22C11, 1/500), anti-APP CT (Y188, 1/500), anti-217 APLP1 (1/1000), anti-APLP2 (1/1000) and anti-GAPDH (1/25000). Blots were revealed using 218 ECL and signal quantification was performed using GelQuant.NET software 219 (BiochemLabSolutions.com). 220
ImmunoCytoFluorescence (ICF) 221
Neurons were grown at 100.000 cells/cm² per well on poly-L-lysine coated coverslips. Neurons 222
were rinsed with PBS and fixed for 15 min in PBS/4% paraformaldehyde. Neurons were washed 223 again twice in PBS for 5 min and processed as described previously (Decock et al., 2016) . 224
Permeabilization and blocking steps were done in PBS/5% skimmed milk/0.3% Triton-X100 225 (M3TPBS); antibodies were incubated in PBS/5% skimmed milk/0.1% Triton-X100 (M1TPBS). 226
Primary antibodies dilutions used: mouse anti-MAP2 (1/1000), rabbit anti-APP (Y188, 1/100) and 227 rabbit anti-GAD65 (D5G2, 1/100). Secondary antibodies dilutions used: goat anti-mouse Alexa 228
Fluor®-488 (1/500), goat anti-mouse Alexa Fluor®-568 (1/500) and goat anti-rabbit Alexa 229
Fluor®-647 (1/500). Images were acquired on Evos FL Auto microscope (Invitrogen) with GFP 230
(Alexa Fluor®-488 or native GFP), TxRed (Alexa Fluor®-568) and CY5 (Alexa Fluor®-647) 231
EVOS LED light cubes and analyzed with ImageJ software. For the quantification of signal area, 232 10X or 20X magnification images were identically thresholded for APP+/+ and APP-/-or Ct and 233 8 CRISPR-Npas4. Area of thresholded images was measured and normalized to the number of cells 234 counted by DAPI staining. For the quantification of the APP expression intensity, image 235 acquisition was performed using 40x objective coverslip-corrected (ThermoFischer Scientific, 236 AMEP4699) in GFP, CY5 (APP) and DAPI channels. A total of 12, 19 and 19 images were 237 acquired to obtained 33, 46 and 51 neurons in the analysis ( Figure 3B ) for CRISPR control (Ct), 238
Oligo2 and Oligo17 respectively. GFP channel images were first 8-bit transformed and thresholded 239 to highlight only GFP staining. A region of interest (ROI) was delimited around GFP+ neurons in 240 the GFP channel (green using "wand tool" in imageJ software and transposed to CY5 (APP) 241 channel (blue). ROI mean intensity is measured using "Analyze" tool of ImageJ software. 242
AICD and CRISPR/Cas9 lentiviral constructions and production 243
We used a lentiviral vector-based approach to express AICD in neurons. AICD50 tagged at the c-244
terminal part with hemagglutinin (HA) was cloned into pLenti CMV/TO Puro lentiviral vector 245 (Addgene #17482). pLenti CMV/TO Puro empty is used as control (Ct). We used a lentiviral 246
vector-based approach to deliver the CRISPR-Cas9 system. We designed sgRNAs "Oligo2" and 247 "Oligo17" to target App mouse gene (Gene ID: 11820), and sgRNA "CRISPR-Npas4" to target 248
Npas4 mouse gene (Gene ID: 225872). sgRNAs were cloned in a lentiviral vector delivering 249 sgRNA, SpCas9 and coexpressing eGFP (Addgene #57818) according to author instructions 250 (Heckl et al., 2014) . The negative control (Ct) used was the lentiviral construct without sgRNA but 251 expressing SpCas9 and eGFP. sgRNA sequences, scores and PAMs are provided in Table 2 in  252 Supplementary material. Briefly, sgRNAs purchased at Sigma-Aldrich (St Louis, MO, USA) were 253 designed using on/off-target score algorithm and cloned into the pL.CRISPR.EFS.GFP plasmid. 254
Vectors were validated by sequencing (Beckman Coulter Genomics, UK), produced and purified 255
using Plasmid Midi kit (Qiagen, Hilden, Germany). Lentiviruses were produced by transfecting 256 HEK293-T cells in 10 cm dishes (2x10 6 cells/dish) with lentiviral CRISPR-Cas9 vectors, pCMV-257 dR8.2 (Addgene#12263) and pMD2.G (Addgene#12259). After 48 h, the supernatant was filtered 258
and incubated with 1/3 (v/v) of LentiX™ Concentrator for 90 min on ice. The collected supernatant 259 was centrifuged at 1500xg for 45 min at 4°C, the pellet was resuspended in 20 µl per dish of 260
Neurobasal® Medium and stored at -80°C until use. Empty backbone of pL-CRISPR.EFS.GFP 261 was used as negative control (Ct) in our studies. 262
Neurons were infected with lentiviruses CRISPR-Cas9 1 day after plating (DIV1). Typically, 20 263 µl of concentrated virus were used to infect 800.000 cells per well of 12 well plate dish. The 264 medium was completely changed after 24 hours and a half media change was carried out every 2-265 3 days thereafter. The neurons were harvested at 7 days in vitro (DIV7) or as indicated. 266
Lentiviral toxicity assay 267
Cell viability was measured by LDH release in the culture medium at DIV7 after lentiviral infection 268
using Cytotoxicity Detection kit (Sigma-Aldrich, St-Louis, MO, USA) according to the 269 manufacturer's instructions. Relative absorbance was measured at 490 nm using a VICTOR 270 9 Multilabel Plate Reader (PerkinElmer, Richmond, VA, USA). Background LDH release was 271 determined in non-infected control cultures. 272
Flow cytometry and cell sorting 273
After DIV7, infected neurons were briefly rinsed with PBS and trypsinized for 2 min. Neurons 274
were mechanically dissociated and filtered through 70 µm Falcon™ Cell Strainers in 50 ml tube 275 containing FBS. Cells were pelleted by centrifugation at 1000xg for 5 min and resuspended in 276 PBS/1% FBS/1mM EDTA. TO-PRO™-3 Iodide (Thermo Fisher Scientific) was used to stain dead 277 cell and exclude them for the sorting. Cells were sorted using a BD FACSAria™III cell sorter (BD 278 Biosciences, San Jose, CA) on the "Flow cytometry and cell sorting -CYTF" UCL platform. The 279 sort parameters used were the following: nozzle 100 µm, sheath pressure 20 psi, drop frequency 280 30 kHz and sort precision 16-32-0. Sample and collection tubes were maintained at 4°C throughout 281 the sort. GFP-negative and positive cells were harvested in PBS/1% FBS/1mM EDTA and 282 centrifuged at 12000xg for 2 min and homogenized in TriPure Isolation Reagent for RNA 283 extraction. 284
Glutamate and GABA measurements 285
Glutamate and γ-aminobutyric acid (GABA) were measured in medium and in cells at DIV7. 286
Briefly, neurons were grown at 200.000 cells/cm² in 12 well plate culture dish. Media were 287 harvested, centrifuged to pellet cell's debris and supplemented with cocktail of proteases inhibitors 288 and frozen at -20°C until use. Cells were scratched in ice cold PBS and pelleted by centrifugation 289 (12.000xg for 3 min at 4°C) then quickly frozen in liquid nitrogen and kept at -80°C until use. For 290 glutamate assay: Media were directly used as are. Cells were prepared according to the 291 manufacturer protocol and measurement was normalized on protein content. For GABA ELISA 292 assay: Media were directly used as are. Cells were lysed by 5 cycles of thawing and freezing in 293 PBS and centrifuged at 12.000xg for 10 min at 4°C. Supernatant was used for the quantification 294 and normalized on protein content. 295
Statistical analysis 296
Microarray analysis: Raw data were analyzed using Bioconductor (R environment). Robust 297
Multiarray Average (RMA) was used for background correction, normalization, probe level 298 intensity calculation and probe set summarization. Gene expression values were compared between 299 APP+/+ and APP-/-neurons at different stage of development DIV3, DIV7 and E18 using the R-300
Limma ( Whitney test were used. If more than two groups were compared, parametric ANOVA with post 313 hoc tests as indicated or non-parametric Kruskall-Wallis were used. (*, p < 0,05; **, p < 0,01; ***, 314 p < 0,001). The number of biological replicate (n) analyzed is indicated in figure legends in the 315 number of independent experiment (N). 316
317
Results 318
APP-dependent expression of Npas4 in differentiated primary neuron cultures 319
Experiments were performed on primary neuron cultures according to the workflow described in 320
Supplementary Figure S1A . Briefly, neurons from embryonic cortex (E18) were cultured for 3 or 321 7 days in vitro (DIV3 or DIV7) and longer (up to DIV14) when necessary. We first characterized 322 the expression of APP family proteins and observed an increase in APP, APLP1 and APLP2 upon 323 differentiation with a peak of expression at DIV 7-8 ( Figure S1B -C), supporting an important role 324 of APP protein family in neuronal maturation. No modifications of APLP1 or APLP2 levels and 325 maturation were observed in APP-/-neurons when compared to APP+/+ at any time point of 326 differentiation studied ( Figure S1D ). Thus, results obtained here in APP-/-neurons can be related 327
to the loss of APP and not to indirect effects resulting from up-or down-regulation of APLP1 or 328 APLP2. Previous studies indicated that AICD is detectable inside the nucleus specifically at DIV6-329 7 (Kimberly et al., 2005) suggesting that AICD-dependent gene transcription is temporally 330 restricted. We checked for AICD production at DIV7 in total lysates of APP+/+, APP+/-and APP-331 /-cultures ( Figure S1E ). AICD was readily detectable in APP+/+ neurons at but only at high 332 exposure time, confirming that it is a transient peptide (Huysseune et al., 2007) with a restricted 333 temporally expression pattern in primary neurons. AICD-dependent transcriptional regulation may 334 therefore only occur within a defined time-period, around DIV7 (and not at DIV3). 335
To investigate this, we performed microarray experiments, which allow description of genome-336 wide expression changes in APP +/+ and APP-/-primary cortical neurons at DIV3 (immature 337 neuronal network), DIV7 (neuronal network with detectable AICD) and in E18 cortical tissue 338 (summarized in Figure S1A ). We used Affymetrix GeneChip®Mouse Transcriptome 1.0 Array and 339
carried out data analysis with the R-Limma (Linear Models for MicroArray Data) package (Ritchie  340  et al., 2015) . The chips used allow the profiling of coding and non-coding (lncRNA, miRNA, 341 pseudogene…) gene expression as well as alternative splicing events. We ran each condition (E18, 342 DIV3, and DIV7) in triplicate (3 chips used for each condition, from independent cultures). We 343 focused here on differentially expressed coding genes, although data were collected for non-coding 344
RNAs (not shown). Strikingly, the overall changes observed (fold changes) were moderate in all 345 conditions (E18, DIV3 and DIV7). Few coding transcripts appear to be differentially expressed 346 when the specific fold change (linear) is set at 1.25, 1.5 or 2 ( Figure 1A) . The Benjamini-Hochberg 347 multiple correction test did not reveal any robust differential gene expression (adjusted p-value 348 <0,05) except as expected for APP (positive control). Gene enrichment analysis was performed 349 using ROAST (Rotation gene set test for complex microarray experiment) procedure to finally 350 identify molecular interaction/reaction networks diagram (Kanehisa and Goto, 2000) also known 351
as KEGG pathway altered in the absence of APP. The first five pathways (in terms of significance), 352
the number of genes modified as well as their direction are shown in Figure 1B . Interestingly, ECM 353
(extracellular matrix)-receptor interaction and Long-term potentiation pathways are modulated in 354 absence of APP at DIV7. Cell-ECM interactions are mediated by transmembrane receptors and cell 355 adhesion proteins, involved in adhesion, differentiation and maturation. Long term potentiation 356 12 (LTP) is a major mechanism in memory formation and learning. Both of these pathways have been 357 associated to APP function (Caceres and Brandan, 1997; Seabrook et al., 1999; Puzzo et al., 2011). 358 To note, we did not measure any expression change ( Supplementary Table 3) of genes identified  359 as AICD target genes (Pardossi-Piquard and Checler, 2012) . 360
We decided to further select genes relevant to described APP cellular function in order to further 361 investigate their regulation by APP. In a set of array (APP+/+, accession number GSM3089741 vs 362
APP-/-accession number GSM3089744) from a primary neurons at DIV7, we noticed a down-363 regulation of (IEGs) in APP-/-neurons ( Figure 1C ). Among them, the activity-dependent 364 transcription factor, Npas4 (Neuronal PAS domain protein 4) was of particular interest. NPAS4 is 365 a neuron-specific IEG, known to be regulated by neuronal activity and involved in synaptic 366 plasticity and synaptic homeostasis. We confirmed by qPCR that the Npas4 mRNA level was 367 decreased at DIV7 in APP-/-neurons compare to APP+/+, but not at DIV3 nor in the cortex at E18 368 ( Figure 1D ). To note, the expression of other early genes (Egr1 and Egr3) previously reported to 369 be involved in APP-dependent gene expression (Hendrickx et al., 2013) were not altered in our 370 conditions ( Figure S2A , S2B). 371
Npas4 expression is AICD-independent 372
Since transcription of APP target genes could involve AICD (Belyaev et al., 2010) , which is 373 produced particularly at DIV7, we inhibited its release by treating neurons with 1µM DAPT for 16 374 h, a well-described non-competitive γ-secretase inhibitor (Dovey et al., 2001) . DAPT treatment 375
induced APP CTFs accumulation (Figure 2A ), indicating that γ-processing thus AICD release were 376 inhibited under these conditions (Hage et al., 2014) . DAPT treatment didn't decrease Npas4 377 expression in APP-/-primary neurons, but indeed increased it in APP+/+. To further address the 378 role of AICD in Npas4 regulation, we transduced primary neurons with a lentiviral vector 379
expressing the 50 C-terminal amino acids of APP (AICD) fused (C-terminus) to the hemagglutinin 380 tag (HA). AICD-HA is detectable in infected cells ( Figure 2C ), and AICD expression in APP-/-381 neurons did not modify Npas4 mRNA levels ( Figure 2D ), confirming that AICD is not involved in 382 APP-dependent Npas4 transcriptional regulation. As some of the APP functions were found to rely 383 on its extracellular soluble fragment (sAPPα), we tested whether the sAPPα can regulate Npas4 384 expression per se. Neuronal cultures were treated with 20 nM of human sAPPα for 16 h ( Figure  385 2E) and Npas4 expression was measured by qPCR. Npas4 mRNA levels increased significantly 386 upon sAPPα addition in APP+/+ neurons, but not in APP-/-( Figure 2F ). These data provide a 387 general insight into APP-dependent Npas4 transcription in neurons. (i) AICD release is not 388 involved in this process; (ii) APP soluble ectodomain (sAPPα) regulates Npas4 expression, only in 389 a context where endogenous APP is expressed. Important to note, glial cells represent about ~16% 390 of total cells in primary cultures, and can indirectly contribute to the mechanisms we observed. 391
However, absence of APP did not change the astrocytic pattern of primary cultures, and astrocytes 392 do note express readily detectable Npas4 levels ( Figure S3A-B ). Hence, our observations reflect 393 APP-dependent Npas4 regulation truly acting in neurons 394 13 The APP-dependent transcriptional regulations we observed were subtle when compared to those 395 reported in the literature, in line with the mild phenotype of APP knockout mice (Muller et al., 396 1994; Zheng et al., 1995) . Although we did not observe compensation of APP loss by APLP 397 overexpression in our model, APP-dependent gene regulations that appear in the close-up could be 398 hidden in the long term or related to functional redundancies with other members of the APP family 399 (Shariati and De Strooper, 2013) . In this line, APP-/-mice brain phenotype is better unraveled by 400 acute down-regulation of APP (Senechal et al., 2007) . We decided therefore to knock-down the 401 APP expression in APP+/+ neurons with a lentiviral-based CRISPR-Cas9 genome editing approach 402 (Jinek et al., 2012) , to test the consequence of acute APP knock-down on Npas4 expression. Nearly 403 ~50% of the cells in culture were infected under our conditions ( Figure S4A-B ) and no lentiviral 404 toxicity was measured ( Figure S4C ). Only neuronal cells were infected, reflecting the tropism of 405 the viral particles for neurons, and not for glial cells. APP expression was monitored by ICF ( Figure  406 3A) and by measuring the intensity of APP signal in GFP-positive (infected) neurons ( Figure 3B ).
407
APP was strongly decreased in neurons infected with viruses expressing the Oligo2 and 17 sgRNA 408 sequences targeting APP exon1 and exon 2, respectively, when compared to Ct. This was 409 confirmed by Western blotting showing the APP expression specifically decreased by about 50%. 410
Importantly, APLP1 and 2 expressions were not altered in cultures infected with Oligo2 and 411
Oligo17 lentiviruses (Figure 3 C) , clearly indicating that off targets mechanisms -a major risk with 412 CRISPR-Cas9 approaches, especially with homologous genes -are not observed in our 413 experimental setup. 414
We decided to measure the expression of Npas4 after APP knock-down selectively in GFP-positive 415
(knock-down) neurons. This was achieved by sorting GFP positive cells by flow cytometry. We 416 used TO-PRO™-3 staining as a viability marker to exclude dead cells from the analysis and set 417 sorting parameters by using non-infected condition (no GFP) and neurons expressing GFP (GFP 418 infected) as standards. Npas4 mRNA levels were measured in these cells by qPCR ( Figure 3D ). 419
Npas4 mRNA was readily decreased in neurons infected with Oligo2-and 17-expressing 420 lentiviruses. Acute APP knock-down achieved with the CRISPR-Cas9 system in primary neurons 421 resulted in the decrease in Npas4 expression, confirming the APP-dependent Npas4 transcriptional 422 expression observed in APP deficient neurons. 423
APP deficiency increases the markers of GABAergic transmission 424
Down-regulation of Npas4 expression in the absence of APP could reflect an impairment in neurite 425 formation and/or synaptogenesis which may lead to deficient in basal neuronal activity. APP was 426 reported to modulate neurite outgrowth and synapse formation (Priller et al., 2006; Young-Pearse 427 et al., 2007; Tyan et al., 2012; Billnitzer et al., 2013) but the mechanisms by which APP modulates 428 synapse formation and plasticity is poorly understood. We first analyzed neuronal arborization at 429 DIV7, when Npas4 expression is decreased. We monitored arborization by measuring the area of 430 the neuron-specific microtubule associated protein2 (MAP2) signal per cell from DIV1 to DIV7 431 ( Figure 4A ). APP-/-neurons extend neurites and no difference was observed at DIV1 to DIV3. The 432 14 absence of APP subtly (but significantly) increased MAP2 signal at DIV7 ( Figure 4B) , indicating 433 the importance of APP for proper neurite arborization. 434
Npas4 is involved in the fine tuning of excitatory/inhibitory homeostasis, by controlling the balance 435 of excitatory and inhibitory inputs on post-synaptic neurons (Lin et al., 2008; Bloodgood et al., 436 2013; Spiegel et al., 2014) . This characterized by the type of neurotransmitter released: typically 437 glutamate for excitatory synapses and GABA for inhibitory synapses. We measured the amount of 438
GABA and glutamate released in medium and present in the cells at DIV7 (Figure 5A-B) . The 439 concentration of GABA is increased by 83% in the medium of APP-/-neurons ( Figure 5A) , and 440 no difference was observed for GABA measured in cells. Strikingly, we observed no significant 441 change in glutamate concentration (cell or medium) in APP-/-neuronal cultures compare to 442 APP+/+ ( Figure 5B ). This is supported by the only slight qualitative modifications in glutamate 443
responses measured by intracellular calcium imaging in APP-/-neurons ( Figure S5 ). GABA is 444 synthetized by the glutamate decarboxylase enzymes (GAD65 and GAD67) that catalyze the 445 decarboxylation of glutamate to GABA. GAD65 synthesizes GABA for neurotransmission, and is 446 therefore active at nerve terminals and synapses. By immunostaining, we observed that GAD65 447 signal is increased in APP-/-neurons compared to APP+/+ neurons ( Figure 5C ). This is not caused 448
by an increase in the relative number of GABAergic neurons in APP-/-cultures compare to APP+/+ 449 ( Figure S6 ), pointing to an increase in GAD65 cellular expression. To further address the effect of 450 APP deficiency on GABAergic neurotransmission, we quantified the expression of the most 451 prevalent GABA receptor subunit, GABARa1 expressed during neuronal development. We found 452
GABARa1 to be slightly but significantly decreased in APP-/-neurons ( Figure 5D ), suggesting 453 complex modifications of GABAergic neurotransmission. In summary, our results indicate that 454 APP deficiency disturbs mainly GABAergic neurotransmission components with a little effect on 455 the excitatory counterpart. 456
Finally, we evaluated whether impairments affecting GABAergic neurotransmission components 457
we observed in vitro in vitro could are relevant in the brain. We quantified the expression of 458 GAD65 in cortices and hippocampi of 3 month old mice deficient for APP (APP-/-) compared to 459 their wild-type counterpart (APP+/+). Consistent increase in GAD65 expression is observed both 460 in cortex ( Figure 6A ) and in hippocampus ( Figure 6B ) of APP-/-mice; indicating that GABAergic 461 neurotransmission component GAD65 is also affected in adult mouse brain and supporting our in 462 vitro findings. 463
Phenotype of NPAS4-deficient neurons mimics APP deficiency 464
As for APP, we used the CRISPR-Cas9 approach in order to silence Npas4 and analyze whether 465 NPAS4 deficiency could recapitulate a major trait observed in APP-/-neurons, i.e. imbalance of 466 inhibitory transmission by the upregulation of GABA release. Given that (i) CRISPR-Cas9 editing 467 is hard to evaluate by quantifying mRNAs expression, (ii) that available antibodies poorly detect 468 NPAS4 in basal conditions, we decided to check the down-regulation of Npas4 gene expression by 469 measuring NPAS4 protein upon depolarization by KCl (Lin et al., 2008) . CRISPR-Cas9-induced 470 silencing resulted in a decrease in NPAS4 by approximately 50% (Figure 7A ), a similar extent to 471 that observed of mRNAs in APP-/-neurons at DIV7 ( Figure 1D ). This downregulation of NPAS4 472
is not due to a lentiviral toxic effect ( Figure S4C ). Strikingly, like for APP-deficient neurons 473 ( Figure 5C ), NPAS4-deficient neurons showed an increase in GAD65 staining ( Figure 7B -C), 474 GAD65 protein expression ( Figure 7D ), and GABA release in the medium ( Figure 67C ) when 475 compared to control neurons. We measured the expression of GABA receptor subunit alpha 1 476 (GABARa1) at DIV7 and observed, like in APP-/-primary neurons, a decrease in protein 477 expression after Npas4 knockdown ( Figure 7D ). 478 479 Discussion 480
One major APP function is to control synaptic formation, transmission and plasticity (Muller et al., 481 2017) . We showed here that APP deficiency in cortical neurons impairs the balance between 482 excitatory and inhibitory synaptic markers, and that this process relies on the activity-dependent 483 transcription factor NPAS4. We initially identified the Npas4 IEG as a potential APP target gene 484 by a non-biased transcriptome profiling approach. The APP-dependent regulation of Npas4 485 expression involves its extracellular domain (sAPPα) but not AICD. APP appears to exert a fine 486 tuning of excitatory/inhibitory synaptic inputs in neurons and its absence enhances, through the 487 downregulation of Npas4, inhibitory GABAergic transmission. 488 However, we did not measure any changes in APLP1 and APLP2 expression in our APP-/-models 496 in agreement with previous observations total brain extracts (Zheng et al., 1995) or in primary 497 cortical neurons (White et al., 1998) . Transcriptional modifications we measured are thus related 498
APP-dependent expression of
to APP per se. APP-dependent transcriptional regulations are subtle, and likely to act by fine-tuning 499 classes of gene involved in neuronal pathway rather than single target genes. In addition, we found 500 that none of the APP/AICD target genes were differentially expressed in APP-/-neurons at DIV3-501 DIV7 or at E18 (See Supplementary Table 3 ). The identification of AICD-dependent gene 502 expression stemmed from studies carried out in an array of in vitro-and -to a lesser extent-in vivo 503 models (for review see Pardossi-Piquard and Checler, 2012; Grimm et al., 2013) . Some of these 504 findings were confirmed or debated in subsequent investigations (Hebert et al., 2006; Chen and 505 Selkoe, 2007; Waldron et al., 2008; Aydin et al., 2011) . AICD-dependent gene transcription and 506
how it relates to APP function appears thus, if not controversial, scarcely understood. 507
We found that the expression of Npas4, an activity-dependent IEG, is downregulated in the absence 508 of APP and particularly at DIV7. Npas4 downregulation was observed it in APP-/-primary neurons 509 and upon acute APP knock-down by a CRISPR-Cas9 approach (Figure 3D) , establishing a causal 510 relation between APP and Npas4 transcription. Furthermore, APP-dependent Npas4 expression at 511 DIV7 does not rely on AICD release, although DIV7 corresponds to the differentiation stage where 512 AICD is readily produced by neurons (Kimberly et al., 2005) . Previous studies indicated that 513 regulation of some APP target genes does not require the generation of AICD (Hicks et al., 2013). 514
Quite strikingly, DAPT treatments, used to block AICD production in our setup, increased Npas4 515 expression in APP+/+ neurons. This effect might imply that inhibition of γ-secretase increases the 516 neuronal activity in an APP-dependent manner (APP-/-neurons showed no modification of Npas4 517 expression after treatment). In line with this, γ-secretase inhibition was shown to increase 518 excitatory postsynaptic currents (EPSCs) (Priller et al., 2006; Restituito et al., 2011) . Further 519
investigations are required to understand this observation. However, one hypothesis could be that 520 the loss of Aβ underlies the DAPT effects we observed. Several studies reported that Aβ depresses 521 AMPA-and NMDA-receptor mediated currents and EPSCs in neurons arguing toward a negative 522 feedback of Aβ on synaptic transmission (Kamenetz et al., 2003; Snyder et al., 2005; Hsieh et al., 523 2006 ). This feedback is not possible in a APP-/-background. Alternatively, studies indicated that 524 inhibition of γ-secretase induces an increase of production of sAPPα (Chen et al., 2015) . In that 525 case, increased activity related to increased sAPPα production would corroborate the results we 526 obtained on Npas4 expression by treating neurons with sAPPα. We also found that sAPPα effects 527 on Npas4 expression are observed only in APP+/+ and not in APP-/-background. This observation 528
indicates that (i) the transcriptional effects of sAPPα require the presence of endogenous APP 529 holoproteins (ii) homophilic ectodomain interactions are likely to be involved. Soluble APP has 530 been shown to rescue many traits of APP-deficient mice (Ring et al., 2007; Weyer et al., 2014) and 531 was suggested to promote its physiological effects by interaction with APP holoprotein (Milosch 532 et al., 2014; Deyts et al., 2016) . 533
Alteration of GABAergic inputs in APP deficient neurons are related to Npas4 534
downregulation 535
In the absence of APP, we observed an increase in neuronal outgrowth and GAD65 signal, as well 536
as increased GABA release in the medium. To note, Npas4 knockdown mimics APP deficiency on 537 GAD65 levels and GABA measurements (Figure 8 ). This supports the hypothesis APP regulates 538 the fine-tuning inhibitory synaptic transmission in the neuronal network through NPAS4. First, this 539 is in agreement with very recent work showing that APP regulates GABAergic neurotransmission 540 during neuronal differentiation (Doshina et al., 2017) . In vivo studies evidenced increased GABA 541 levels in the brain of APP-/-mice (Lee et al., 2010) . Secondly, the finding that APP-dependent 542 neuronal processes are mediated by NPAS4 is relevant to experimental evidences reported in 543 previous studies. NPAS4 possesses unique features among the IEGs (Sun and Lin, 2016): (i) it is 544 only expressed in neurons; (ii) it is activated selectively by neuronal activity; (iii) it has been shown 545
to be important to shape glutamatergic and GABAergic synaptic inputs. NPAS4 is implicated in a 546 transcriptional program that regulates neuronal firing responses to excitatory transmission by 547 enhancing inhibition (Lin et al., 2008) , and is critical for the homeostatic mechanisms that keep 548 neuronal firing in response to stimuli within normal levels (Spiegel et al., 2014) . Increasing the 549 excitability of a set of neurons leads to changes in both their input and axonal synapses. NPAS4 is 550 necessary for modulating the inputs synapses but not the axonal synapses of these neurons (Sim et 551 al., 2013) . NPAS4 is induced in excitatory neurons, where it promotes increased numbers of 552 inhibitory synaptic inputs. (Spiegel et al., 2014) . Altogether, these specific functions of NPAS4 553 correlate well with our main observation that APP-dependent Npas4 expression is related to the 554 upregulation of the GABAergic system in APP-deficient neurons. This is not restricted to primary 555 neurons, since we measured an increase in markers of GABAergic synapses in adult mouse brain. 556
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The overall effect of APP deficiency of neuronal network activity and synaptic transmission needs 557 further neurophysiological investigations that are beyond the scope of the present study. Important 558 points must be kept in mind here. First, GABAergic transmission shifts from excitatory to 559 inhibitory during development (Ben-Ari, 2002) , and our findings should be evaluated by 560 electrophysiological recordings in mature neurons. For instance, we found that the level of GABA 561 receptor subunit alpha 1 (GABARα1) was diminished in the absence of APP and in NPAS4-562 deficient neurons. This is in agreement with recent study showing that GABARα1 is particularly 563 decrease in hippocampus of APP-/-mice (Chen et al. 2017) correlating with a decrease in IPSC 564
amplitude. But on the other hand, it suggests that increases in GABA release in APP-deficient 565 models may not result in a net increase of inhibitory transmission, or at least there is a complex 566 modulation of neuronal response to GABA. 567
Possible relevance to the AD pathophysiology 568 APP plays a central role in the onset and progression of AD by releasing the Aβ peptide, but, APP 569 deficiency is more difficult to correlate to the pathology. Still, it is admitted that impairment of 570 APP function per se, either caused by FAD mutations or upon ageing, may contribute to neuronal 571 dysfunction occurring in the disease. For instance, the phenotype of APP deletion in the CNS is 572 age-dependent (Priller et al., 2006) . Upon aging, impairments in learning and memory associated 573 with deficits in LTP are observed in APP-deficient mice (Ring et al., 2007) . The role of APP in 574 maintaining spine architecture is supported by the reduction in dendritic length and branching as 575 well as in total spine density in old APP-deficient mice (Lee et al., 2010; Tyan et al., 2012) . A 576 severe decrease in metabolic activity was also observed in presynaptic densities of APP KO 577 animals (Lassek et al., 2017) . This is an important feature, because bioenergetics and metabolic 578 activity are fueling the synthesis of neuromediators (glutamate and consequently GABA), and 579
providing energy supply and calcium buffering essential for synaptic function and plasticity. 580
Significantly lower levels of GABA and glutamate were measured in the temporal cortex of AD 581 patients, pointing to deficient synaptic function and an imbalance in neuronal excitatory/inhibitory 582 transmission (Gueli and Taibi, 2013) . These observations unambiguously support changes in 583 neurotransmission in AD (and even in ageing brain), but the mechanisms underlying this process 584 are hardly understood. Here we found that neuronal activity by itself, sensed by the NPAS4 IEG, 585 reshapes synaptic GABAergic inputs on neurons, in line with recently reported modifications of 586 GABA transmission in AD models (Doshina et al., 2017) . Very interestingly, NPAS4 expression 587 decreases along with AD progression, particularly at Braak NFT stages (I-II) corresponding to 588 lesions developed in transentorhinal/entorhinal cortex (Miyashita et al., 2014) . Downregulation of 589
GABAergic transmission could also underlie the increased risk for unprovoked seizures observed 590 in individuals with AD compared to non-demented individuals of the same age (Friedman et al., 591 2012) . 592
In conclusion, our main observation that APP deficiency in neurons is integrated by the activity-593 dependent NPAS4 IEG to further re-modulate inhibitory and excitatory neuronal inputs, provides 594 new insight to understand the role of APP in synaptic activity, but also a mechanistic frame to 595 further explore the impairments of network activity in AD. 596 597 20 were quantified in two independent experiments for each condition (n=33 N=2 
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